Formula Growth’s HCA Healthcare HCA Stock Holding History

Formula Growth’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95M	Hold	5,000	–	–	0.69%	49
2026 Q1	$2.37M	Hold	5,000	–	–	1.07%	31
2025 Q4	$2.33M	Sell	5,000 -1,000	-17%	-$464K	0.9%	42
2025 Q3	$2.56M	Hold	6,000	–	–	0.91%	49
2025 Q2	$2.3M	Sell	6,000 -1,000	-14%	-$360K	0.87%	47
2025 Q1	$2.42M	Sell	7,000 -1,000	-13%	-$322K	0.98%	43
2024 Q4	$2.4M	Sell	8,000 -1,000	-11%	-$349K	0.81%	51
2024 Q3	$3.66M	Sell	9,000 -3,000	-25%	-$1.1M	1.26%	27
2024 Q2	$3.86M	Sell	12,000 -3,500	-23%	-$1.14M	1.4%	22
2024 Q1	$5.17M	Sell	15,500 -5,000	-24%	-$1.53M	1.65%	15
2023 Q4	$5.55M	Hold	20,500	–	–	1.78%	6
2023 Q3	$5.04M	Sell	20,500 -2,500	-11%	-$684K	1.72%	8
2023 Q2	$6.98M	Sell	23,000 -3,000	-12%	-$834K	2.22%	5
2023 Q1	$6.86M	Sell	26,000 -1,000	-4%	-$254K	2.21%	5
2022 Q4	$6.48M	Hold	27,000	–	–	1.83%	11
2022 Q3	$4.96M	Hold	27,000	–	–	1.42%	18
2022 Q2	$4.54M	Hold	27,000	–	–	1.26%	26
2022 Q1	$6.77M	Hold	27,000	–	–	1.28%	23
2021 Q4	$6.94M	Hold	27,000	–	–	1.23%	25
2021 Q3	$6.55M	Hold	27,000	–	–	0.94%	35
2021 Q2	$5.58M	Hold	27,000	–	–	0.77%	39
2021 Q1	$5.08M	Hold	27,000	–	–	0.73%	44
2020 Q4	$4.44M	Sell	27,000 -3,000	-10%	-$439K	0.74%	34
2020 Q3	$3.74M	Hold	30,000	–	–	0.7%	40
2020 Q2	$2.91M	Hold	30,000	–	–	0.49%	58
2020 Q1	$2.7M	Hold	30,000	–	–	0.52%	52
2019 Q4	$4.43M	Hold	30,000	–	–	0.56%	51
2019 Q3	$3.61M	Hold	30,000	–	–	0.54%	49
2019 Q2	$4.05M	Hold	30,000	–	–	0.58%	44
2019 Q1	$3.91M	Hold	30,000	–	–	0.55%	47
2018 Q4	$3.73M	Hold	30,000	–	–	0.61%	44
2018 Q3	$4.17M	Hold	30,000	–	–	0.48%	50
2018 Q2	$3.08M	Hold	30,000	–	–	0.34%	65
2018 Q1	$2.91M	Hold	30,000	–	–	0.35%	70
2017 Q4	$2.63M	Hold	30,000	–	–	0.35%	60
2017 Q3	$2.39M	Hold	30,000	–	–	0.38%	64
2017 Q2	$2.62M	Hold	30,000	–	–	0.45%	59
2017 Q1	$2.67M	Hold	30,000	–	–	0.56%	52
2016 Q4	$2.22M	Hold	30,000	–	–	0.52%	62
2016 Q3	$2.27M	Hold	30,000	–	–	0.51%	69
2016 Q2	$2.31M	Hold	30,000	–	–	0.56%	58
2016 Q1	$2.34M	Hold	30,000	–	–	0.56%	62
2015 Q4	$2.03M	Buy	+30,000	New	+$2.09M	0.47%	75

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Formula Growth's HCA Position: Q2 2026 in Review

Formula Growth held its HCA Healthcare (HCA) position steady in Q2 2026 at 5,000 shares worth $1.95M. The position accounts for 0.69% of the portfolio, ranked #49.

Formula Growth first reported a position in HCA in Q4 2015 and has held it in 43 quarters since. The position peaked at $6.98M in Q2 2023. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Formula Growth held 5,000 shares of HCA Healthcare worth $1.95M as of Q2 2026.
Formula Growth left its HCA Healthcare share count unchanged in Q2 2026.
HCA Healthcare made up 0.69% of Formula Growth's portfolio in Q2 2026, its #49 holding.
Formula Growth first reported a position in HCA Healthcare in Q4 2015 and has held it in 43 quarters since.
Formula Growth's HCA Healthcare position peaked at $6.98M in Q2 2023.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.